Table 3.
MetS (n=67) | Baseline | Final | P-value |
---|---|---|---|
Weight | 82.5±16.3 | 79.8±15.7 | <0.001* |
BMI (kg/m2) | 30.6±4.7 | 29.6±4.4 | <0.001* |
WC (cm) | 99.3±13.0 | 96.3±11.4 | <0.001* |
BMM (kg)(BMP [%]) | 47.8±11.7 (57.9[%]) | 47.3±11.4 (59.3[%]) | <0.001* |
BFP (%) | 38.4±7.1 | 37.0±7.3 | <0.001* |
FPG (mg/dL) | 105.8±23.6 | 100.1±16.2 | <0.001* |
FSI (mIU/L) | 16.2±13.2 | 11.3±8.1 | <0.001* |
HOMA-IR | 4.4±4.1 | 2.9±2.7 | <0.001* |
TC (mg/dL) | 203.0±39.0 | 191.1±36.9 | <0.001* |
TG (mg/dL) | 165.9±95.3 | 131.2±72.5 | <0.001* |
HDL-C (mg/dL) | 44.8±8.9 | 43.0±8.1 | <0.01* |
LDL-C (mg/dL) | 125.8±29.3 | 118.0±27.3 | <0.01* |
Systolic BP (mmHg) | 141.9±12.0 | 130.7±12.6 | <0.001* |
Diastolic BP (mmHg) | 86.4±8.8 | 78.9±8.1 | <0.001* |
Non-MetS (n=107) | Baseline | Final | P-value |
Weight (kg) | 66.2±11.7 | 64.1±11.1 | <0.001* |
BMI (kg/m2) | 25.7±3.4 | 24.9±3.3 | <0.001* |
WC (cm) | 86.4±9.3 | 82.7±8.5 | <0.001* |
BMM (kg) (BMP [%]) |
39.8±6.5 (60.1%) | 39.2±6.1 (61.2%) | <0.001* |
BFP (%) | 35.8±5.2 | 34.4±5.4 | <0.001* |
FPG (mg/dL) | 90.8±10.3 | 90±5.9 | NS |
FSI (mIU/L) | 6.6±3.8 | 6.0±3.6 | NS |
HOMA-IR | 1.5±0.9 | 1.4±0.8 | NS |
TC (mg/dL) | 205.0±33.0 | 191.5±29.5 | <0.001* |
TG (mg/dL) | 82.6±36.1 | 74.4±33.5 | <0.01* |
HDL-C (mg/dL) | 58.3±12.4 | 55.8±11.7 | <0.001* |
LDL-C (mg/dL) | 123.9±28.5 | 113.6±25.8 | <0.001* |
Systolic BP (mmHg) | 123.6±14.4 | 116.5±12.7 | <0.001* |
Diastolic BP (mmHg) | 74.2±9.5 | 70.6±8.1 | <0.001* |
Notes: *P-value <0.05 and bold values are statistically significant.
Abbreviations: LM, lifestyle modification; MetS, metabolic syndrome; NS, nonsignificant; BMI, body mass index; WC, waist circumference; BFP, body fat percentage; BMM, body muscle mass; BMP, body mass percentage; FPG, fasting plasma glucose; FSI, fasting serum insulin; HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; BP, blood pressure.